BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)
CUSIP: 09075V102
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
- Shares outstanding
- 239,647,920
- Total 13F shares
- 26,613,030
- Share change
- +20,013,131
- Total reported value
- $1,776,088,789
- Put/Call ratio
- 83%
- Price per share
- $66.74
- Number of holders
- 108
- Value change
- +$1,335,873,540
- Number of buys
- 95
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 09075V102?
CUSIP 09075V102 identifies BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09075V102:
Top shareholders of BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
1.1%
|
2,612,117
|
$152,548,000 | — | 31 Mar 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.93%
|
2,228,130
|
$130,123,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
0.31%
|
738,185
|
$43,110,000 | — | 31 Mar 2020 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.2%
|
469,566
|
$24,867,000 | — | 31 Mar 2020 | |
| Redmile Group, LLC |
13F
|
Company |
0.07%
|
170,200
|
$9,940,000 | — | 31 Mar 2020 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.03%
|
60,000
|
$3,622,000 | — | 31 Mar 2020 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.02%
|
56,674
|
$2,988,000 | — | 31 Mar 2020 | |
| Vident Investment Advisory, LLC |
13F
|
Company |
0.02%
|
50,619
|
$2,957,000 | — | 31 Mar 2020 | |
| Avitas Wealth Management LLC |
13F
|
Company |
0.01%
|
33,456
|
$1,954,000 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
26,815
|
$1,566,000 | — | 31 Mar 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.01%
|
20,704
|
$1,209,000 | — | 31 Mar 2020 | |
| Laurion Capital Management LP |
13F
|
Company |
0.01%
|
20,169
|
$1,178,000 | — | 31 Mar 2020 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.01%
|
20,000
|
$1,168,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
13,652
|
$798,000 | — | 31 Mar 2020 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
13,249
|
$774,000 | — | 31 Mar 2020 | |
| American Portfolios Advisors |
13F
|
Company |
0.01%
|
12,314
|
$719,138 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
11,441
|
$668,000 | — | 31 Mar 2020 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0%
|
10,000
|
$584,000 | — | 31 Mar 2020 | |
| COMERICA BANK |
13F
|
Company |
0%
|
11,133
|
$532,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0%
|
7,673
|
$448,000 | — | 31 Mar 2020 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
6,209
|
$363,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
6,046
|
$353,000 | — | 31 Mar 2020 | |
| Paloma Partners Management Co |
13F
|
Company |
0%
|
5,509
|
$322,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
4,890
|
$286,000 | — | 31 Mar 2020 | |
| SG Americas Securities, LLC |
13F
|
Company |
0%
|
3,309
|
$193,000 | — | 31 Mar 2020 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0%
|
3,033
|
$177,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,048
|
$120,000 | — | 31 Mar 2020 | |
| CREDIT AGRICOLE S A |
13F
|
Individual |
0%
|
1,875
|
$110,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
331
|
$20,000 | — | 31 Mar 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
261
|
$15,000 | — | 31 Mar 2020 | |
| Community Bank, N.A. |
13F
|
Company |
0%
|
200
|
$12,000 | — | 31 Mar 2020 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
200
|
$11,000 | — | 31 Mar 2020 | |
| QCI ASSET MANAGEMENT INC/NY |
13F
|
Company |
0%
|
75
|
$4,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
50
|
$3,000 | — | 31 Mar 2020 | |
| Carroll Financial Associates, Inc. |
13F
|
Company |
0%
|
45
|
$2,000 | — | 31 Mar 2020 | |
| AGF INVESTMENTS INC. |
13F
|
Company |
0%
|
15
|
$1,000 | — | 31 Mar 2020 | |
| Sowell Financial Services LLC |
13F
|
Company |
0%
|
10
|
$1,000 | — | 31 Mar 2020 |
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q2 2020
As of 30 Jun 2020,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,613,030 shares.
The largest 10 holders included
FMR LLC, Redmile Group, LLC, PRIMECAP MANAGEMENT CO/CA/, Artal Group S.A., Artisan Partners Limited Partnership, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, DEUTSCHE BANK AG\, HealthCor Management, L.P., and Candriam Luxembourg S.C.A..
This page lists
108
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
36
Q2 2020 holders
108
Holder diff
72
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.